Gerresheimer AG, a German manufacturer of primary packaging for medical and pharmaceutical industries, is expanding to meet increasing pharmaceutical and small-batch demand.
Gerresheimer expanded its small-batch plastics production to meet demand for projects with a smaller number of units or that are being commercialized.
The company has seen a "growing number of development projects for pharmaceutical and medical technology products," it said in a news release. "Prior to batch production, these products are subjected to a protracted development and approval process, for which small numbers of units are often required as samples."
Gerresheimer converted existing production space in Wackersdorf, Germany, into a 5,380-square-foot clean room and added a new, 15,600-square-foot building with clean room and office space.
It invested a "double-digit sum in the millions" in the new small-batch-dedicated space, which produces patch pumps for administering medication, drug containers for injection without needles, point-of-care tests, infusion sets for X-ray contrast agents, syringes, and other products and components.
The small-batch production "ensures the required product quality, as well as complete batch documentation at the level of subsequent large-batch production," the company said. The small batches can then be transferred directly to large-scale production.
Gerresheimer is also expanding its clean room space in Pfreimd, Germany, which manufactures products like lab disposables, pen systems, infusion sets, lancing devices, pumps, auto injectors, inhalers and catheters, with a new building.
The building will be used for additional assembly lines for a "major order" from a pharmaceuticals customer, a news release said. There will be a total of 29 automated assembly lines at the location, it said.
Construction on the building started in October 2020. The company expects it to be complete in August 2022.
"The new connecting building offers our customers clear advantages for the production of sophisticated pharmaceutical and medical technology products," Oliver Burgel, global executive vice president of operations, procurement, HR and quality at Gerresheimer, said in a statement.
"With its highly modern technology, the building is at the same time an important building block for assuring the future of our production facility in Pfreimd," Burgel said.